Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients Journal Article


Authors: Parmigiani, R. B.; Bettoni, F.; Vibranovski, M. D.; Lopes, M. H.; Martins, W. K.; Cunha, I. W.; Soares, F. A.; Simpson, A. J. G.; de Souza, S. J.; Camargo, A. A.
Article Title: Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients
Abstract: Cancer/testis (CT) antigens are immunogenic proteins expressed in normal gametogenic tissues and in different types of tumors. CT antigens are promising candidates for cancer immunotherapy, and the identification of novel CT antigens is a prerequisite for the development of cancer vaccines. We have identified a CT antigen, named CTSP-1, with partial similarity to the breast differentiation antigen NY-BR-1. CTSP-1 presents several splicing and polyadenylation variants and has a very restricted expression pattern among normal tissues. CTSP-1 is exclusively expressed in normal testis and is aberrantly expressed in 47.6% (10 of 21) of tumor cell lines and in 44.4% (75 of 169) of tumors from different histological types. The highest percentages of positive expression were observed in melanomas (59.0%) followed by prostate (58.0%) and lung (57.0%) tumors. CTSP-1 is part of a highly conserved gene family, and members of this family also have a restricted expression pattern and similar protein structure. Antibodies against members of this gene family were detected in 10% (14 of 141) of plasma samples from patients with a wide spectrum of tumors. The highest percentages of antibody response were observed in patients with prostate (20.8%), thyroid (20.0%), and breast (16.6%) tumors. Because of its very restricted expression pattern in normal tissues and immunogenicity in different types of tumors, CTSP-1 should be considered a promising candidate for cancer immunotherapy. © 2006 by The National Academy of Sciences of the USA.
Keywords: immunohistochemistry; controlled study; human tissue; human cell; neoplasms; animals; mice; cancer immunotherapy; melanoma; reverse transcription polymerase chain reaction; gene expression; gene expression profiling; tumor antigen; nuclear proteins; lung tumor; gene expression regulation, neoplastic; prostate; molecular sequence data; immunotherapy; antigens, neoplasm; messenger rna; blood sampling; protein purification; rna, messenger; cancer testis antigen; glioblastoma; nucleotide sequence; breast tumor; prostate tumor; antibody response; recombinant protein; alternative splicing; 5 aza 2' deoxycytidine; humoral immunity; thyroid tumor; testis; complementary dna; multigene family; uterus tumor; gastrointestinal tumor; polyadenylation; variation (genetics); ctsp 1 protein; ny br 1 protein
Journal Title: Proceedings of the National Academy of Sciences of the United States of America
Volume: 103
Issue: 48
ISSN: 0027-8424
Publisher: National Academy of Sciences  
Date Published: 2006-11-28
Start Page: 18066
End Page: 18071
Language: English
DOI: 10.1073/pnas.0608853103
PUBMED: 17114284
PROVIDER: scopus
PMCID: PMC1838707
DOI/URL:
Notes: --- - "Cited By (since 1996): 15" - "Export Date: 4 June 2012" - "CODEN: PNASA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew John Simpson
    31 Simpson